The Walden Group is a strategic investment banking and consulting firm focused on the healthcare industry. Strategic Healthcare Investment Banking and Consulting.
A World-Class Industry Leader in Healthcare Mergers and Acquisitions
Healthcare Expertise and Experience. With a 20-year proven track record, The Walden Group has served the healthcare industry as a specialized investment banking and consulting firm. We focus on the strategic interests of medical device, diagnostic, healthcare IT, medical services, distribution, specialized pharmaceutical, dental and other healthcare companies.
Wall Street M&A Expertise Combined with Hands-on Strategic Healhcare Consulting. We offer sophisticated M&A and other investment banking services like a "bulge bracket" firm, but without an assembly-line process. We also provide pragmatic strategic consulting services by principals who have healthcare executive experience at major firms. Our close-to-operations perspective provides critical texture to our M&A work, and our transactional experience infuses a real-world practicality to our consulting work.
Worldwide Network of Relationships. As healthcare industry experts, we hit the ground running and build-on ongoing relationships with major operating companies and financial sponsors. These relationships have been honed during the many transactions, trade show appearances and speaking engagements we conduct every year. In addition, more than 5,000 individuals around the world receive our Strategic Healthcare M&A Report on a quarterly basis. We are a known quantity worldwide.
Rapid Deployment Force. With decades of healthcare industry expertise, we operate on a savvy, streamlined, client-focused basis. Without any "red tape", learning curve or need to develop relationships from scratch, The Walden Group can quickly and methodically execute fitted transactions and deliver value-added consulting projects
Research Driven. Our goal is to equip our clients with a thorough understanding of industry trends and challenges and provide effective solutions. We closely monitor mergers, acquisitions, strategic alliances and technology transfers within healthcare, as well as changes in government policies and regulations. We track product lines, distribution methods, strategic direction, and manufacturing capabilities of nearly 20,000 companies within our niche, from manufacturers, to distributors, to information technology companies, to service firms of all kinds. We monitor product lines at the customer-vendor level, noting medical specialties and subspecialties addressed. We record product line information in more than 650 such categories, enabling us to pinpoint, with extreme accuracy, strategic matches between companies, whether of a horizontal, vertical, diversification or investment nature.
About Walden Group
The Walden Group, Inc. 560 White Plains Rd. Tarrytown, NY 10591 914.332.9700 firstname.lastname@example.org www.waldenmed.com
Diagnostic Imaging Market Developments
Diagnostic Imaging Market Picking Up. The global diagnostic imaging devices market was valued at USD 26,477.1
million in 2014 and is expected to grow at a CAGR of 5.2% from 2014 to 2020, to reach an estimated value of USD
35,793.4 million in 2020.(Source: Persistence Market Research). The global diagnostic imaging market is growing at a
moderate rate due to increasing prevalence of chronic diseases and injuries, and the growing aging population. More
accurate Improved diagnostics – facilitating earlier discovery of disease and wellness – technology advances are also
fueling growth, despite cost containment measures promoted by government and private payors
3D Imaging Market a Key Accelerator. The North American 3D imaging market is expected to grow from $4.9b to $16.6b
at a CAGR of 27.5% due its more comprehensive visibility and incisive diagnostics. New partnerships spurring the 3D
imaging market include Konica Minolta with STEAMTrax, and Panasonic with Leica Camera AG. Various 3D imaging
providers such as Konica Minolta, Google, Inc., Lockheed Martin, Able Software, Panasonic, Agilent Technologies, GE
Healthcare, Philips Healthcare, and TomTec Imaging solutions are offering advanced 3D imaging solutions, technologies,
and devices pertaining to the needs of both diverse verticals.
Diagnostic Imaging Proven to Save Costs. Researchers at Harvard Medical School have determined that the length of a
patient’s hospital stay is reduced by one day for every $385 spent on medical imaging equipment. Such investments could
lead to savings of about $3,000 per patient. Hospitals are using IT systems not only to archive patient files but also to
optimize processes, supply systems, and communications.
Molecular Imaging: The Key to Earlier Detection of Diseases. Diagnostic imaging is often not used until the
consequences of an illnes